The management of intraductal papillary mucinous neoplasm (IPMN) continues to evolve. In
particular, the indications for resection of branch duct IPMN have changed from early …

This study group aimed to revise the 2017 international consensus guidelines for the
management of intraductal papillary mucinous neoplasm (IPMN) of the pancreas, and …

Evidence-based guidelines on the management of pancreatic cystic neoplasms (PCN) are
lacking. This guideline is a joint initiative of the European Study Group on Cystic Tumours of …

Pancreatic cysts are being identified with increasing frequency as a result of the escalating
use of crosssectional imaging, typically for unrelated reasons. 1, 2 The incidence of …

Objective: We aimed to determine the unbiased mortality rates for pancreatic surgery
procedures at the national level through a comprehensive analysis of every inpatient case in …

Pancreatic cancer is still a dismal disease. The high mortality rate is mainly caused by the
lack of highly sensitive and specific diagnostic tools, and most of the patients are diagnosed …

Background: There are no established guidelines for pathologic diagnosis/reporting of
intraductal papillary mucinous neoplasms (IPMNs). Design: An international …

Pancreatic adenocarcinoma is one of the deadliest malignancies worldwide, mainly due to
frequent diagnosis at an advanced stage and its strong chemoresistance. Tumor …

Abstract Background/Objectives: Intraductal papillary mucinous neoplasms (IPMNs) are a
cystic precursor to pancreatic cancer. IPMNs deemed clinically to be at high-risk for …

Objectives: To describe the characteristics of intraductal papillary mucinous neoplasms
(IPMNs) with predominant involvement of the main pancreatic duct (MPD), analyzing …